In Focus: Small molecules
Small molecules can be used throughout the development of induced pluripotent stem-cell derived cell therapies for reprogramming, maintenance and differentiation. But it can often be difficult to choose the right supplier for you as it’s not always clear which guidelines cell therapy manufacturers should be following around using small molecules.
In this In Focus feature, we’ll be exploring the application of small molecules for stem cell-derived cell therapies and investigating how to choose the right quality reagents as an essential part of the development process.
Infographic
Enhanced quality small molecules as ancillary materials
Standard research reagents are suitable for the early stages of cell therapy development, but to ensure later downstream success investing in high-quality ancillary products at the research phase is important.
View this infographic to discover the benefits of Ancillary Material Grade small molecules and how switching early can reduce the risk, time, and cost associated with revalidating assays and protocols.
Interview
Are all small molecules the same? How do the small molecules used in cell culture differ from drugs or active pharmaceutical ingredients?
We spoke to Rob Felix and Sarah Hillary to get some insight into how small molecules are used to improve the effectiveness of reprogramming, cell expansion and differentiation and hear their expertise on the regulatory landscape for ancillary reagents in cell and gene therapy.
In association with
